Invasive Candidiasis
📧 Sign up to get email alerts when something new happens for Invasive Candidiasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Variability of Fluconazole Concentration in Critically Ill Patients
This clinical trial update reports variability in fluconazole concentrations among critically ill patients with invasive candidiasis and dis…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients
The clinical trial evaluated the impact of a caspofungin loading dose in ICU patients with invasive candidiasis. The study status is complet…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Pharmacokinetics of Micafungin in Critically Ill Patients
This clinical trial update reports the completed pharmacokinetic study of micafungin in critically ill patients. The trial focused on pharma…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Optimal Dosage of Caspofungin in Critically Ill Patients [Phase 4]
A Phase 4 trial evaluating the optimal dosage of caspofungin in critically ill patients with suspected invasive candidiasis has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-21Clinical Trial Update: A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis [Phase 3]
A Phase 3 randomized trial comparing anidulafungin to fluconazole for candidemia and invasive candidiasis was terminated; results were poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Empirical Antifungal Treatment in ICUS [Phase 3]
A Phase 3 clinical trial evaluating empirical antifungal treatment for invasive candidiasis has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia [Phase 3]
Phase 3 trial comparing micafungin to liposomal amphotericin B (AmBisome) for invasive candidiasis and candidemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug [Phase 1]
A Phase 1 study evaluating the safety and drug blood levels of micafungin (Mycamine) in infants and toddlers with invasive candidiasis, esop…
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections
Clinical trial update describing outcomes of patients with severe Candida albicans infections who did not respond to fluconazole treatment.
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) [Phase 2]
A Phase 2 pilot feasibility trial of MK-0991 in patients at high risk for invasive candidiasis in a critical care setting; the study was ter…
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients [NA]
This completed trial compared beta-D-glucan–guided surveillance with preemptive anidulafungin versus standard care in surgical ICU patients …
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Effect of Weight and/or Obesity on Caspofungin Drug Concentrations [Phase 4]
Phase 4 study assessing how weight and obesity influence caspofungin drug concentrations; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System [Phase 3]
A Phase 3 trial comparing anidulafungin to caspofungin for serious Candida infections in immunocompromised patients was terminated; results …
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) [Phase 3]
Phase 3 trial results for caspofungin acetate (MK0991) in Chinese adults with esophageal candidiasis or invasive candidiasis were completed …
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis [Phase 4]
Pfizer completed a Phase 4 trial evaluating the safety and efficacy of anidulafungin (Eraxis) in patients with candidemia or invasive candid…
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Anidulafungin Pharmacokinetics in Intensive Care Unit Patients
The document provides an update on the pharmacokinetics of anidulafungin in intensive care unit patients with invasive candidiasis or candid…
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) [Phase 3]
A Phase 3 study evaluating caspofungin (MK0991) in Japanese patients with invasive Candida or invasive Aspergillus infections has completed,…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study [Phase 3]
Phase 3 trial of anidulafungin for candidemia and invasive candidiasis in intensive care patients completed. Results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) [Phase 4]
Phase 4 randomized trial evaluating caspofungin prophylaxis followed by pre-emptive therapy for invasive candidiasis in ICU patients; the st…
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis [Phase 4]
Phase 4 open-label, non-comparative trial assessing a short course of IV anidulafungin, with optional oral voriconazole, for candidemia and …
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: CRITIC - Treatment of Candidemia and Invasive Candidiasis [Phase 4]
Phase 4 clinical trial update for the CRITIC study evaluating treatment of candidemia and invasive candidiasis; the study sponsored by Gilea…
-
CLINICAL_TRIALS trial_result · 2009-03-24Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) [Phase 3]
A multicenter Phase 3 randomized trial compared two dosing regimens of an antifungal drug for invasive candidiasis; the study is completed a…
-
CLINICAL_TRIALS trial_result · 2008-10-21Clinical Trial Update: The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis [Phase 3]
This Phase 3 trial compares Anidulafungin with a comparator in patients with candidemia or invasive candidiasis to evaluate safety and effic…
-
CLINICAL_TRIALS trial_result · 2008-10-21Clinical Trial Update: The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. [Phase 2]
A Phase 2 trial evaluating intravenous anidulafungin for invasive candidiasis has completed. The study assessed safety and effectiveness in …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Anidulafungin Versus Fluconazole in the Treatment of Candidemia [Phase 3]
Phase 3 trial comparing anidulafungin to fluconazole for candidemia has completed.